—

Hinge Health, Inc.(HNGE)— 同类公司组

数据截至2026-09-24 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Hinge Health, Inc.的Closelook综合评分为57/100,在同类公司组内排名第7位(共9家)——组内评分最高的是Halozyme Therapeutics Inc(74/100)。

名称综合动量质量估值信号距52周高点
HNGE Hinge Health, Inc.57946335ok4.8%
HQY HealthEquity Inc61596945info17.7%
VEEV Veeva Systems Inc Class A60877432bull12.8%
BTSG BrightSpring Health Services, Inc. Common Stock48532540info24%
TEM Tempus AI, Inc. Class A Common Stock38691814bull26.6%
HALO Halozyme Therapeutics Inc74969445ok1.4%
DXCM DexCom Inc66858036neutral5.2%
ARGX argenx NV ADR64747327ok10.3%
ONC BeiGene, Ltd.64796332ok6.6%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-09-24

Quick answers

Hinge Health, Inc.在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:HealthEquity Inc (HQY)、Veeva Systems Inc Class A (VEEV)、BrightSpring Health Services, Inc. Common Stock (BTSG)、Tempus AI, Inc. Class A Common Stock (TEM)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)、argenx NV ADR (ARGX)、BeiGene, Ltd. (ONC)。

HNGE相对同类公司的评分如何?

Hinge Health, Inc.的综合评分为57/100,组内排名第7位(共9家),截至2026-09-24;组内最高综合评分为Halozyme Therapeutics Inc(74/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelook universe

then Health Information Services, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.